0001437749-21-000366.txt : 20210107 0001437749-21-000366.hdr.sgml : 20210107 20210107162047 ACCESSION NUMBER: 0001437749-21-000366 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20210101 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210107 DATE AS OF CHANGE: 20210107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 21514428 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 8-K 1 bioli20210107_8k.htm FORM 8-K bioli20210107_8k.htm
false 0000834365 0000834365 2021-01-01 2021-01-01
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 1, 2021
 
BIOLIFE SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
001-36362
 
94-3076866
(State or other jurisdiction of
incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
3303 Monte Villa Parkway,
Bothell, WA 98021
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code: (425) 402-1400
 
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading symbol
Name of exchange on which registered
BioLife Solutions, Inc. Common Stock
BLFS
NASDAQ Capital Market
 
 

 
Item 5.02.     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
  
On January 1, 2021, Biolife Solutions, Inc. (the “Company”) appointed Sarah Aebersold as Vice President, Global Human Resources.
 
Ms. Aebersold, age 45, joined the Company in February 2020 as Senior Director, Global Human Resources & Administration. In that role, Ms. Aebersold oversaw human resources programs in the areas of employee relations, talent acquisition, benefits, compensation, coaching, training and development, policy, and data management. Prior to joining the Company, Ms. Aebersold served in a variety of human resources roles with companies including MCG Health, a healthcare solutions provider (2016-2020, most recently as Head of Human Resources and Administration), Spacelabs Healthcare, a manufacturer of medical equipment (2014-2016, 2012-2013, most recently as Senior Manager, Human Resources), T-Mobile, a mobile communication company, (2013-2013, most recently as Human Resource Manager), Seattle Children’s Hospital, a children’s hospital (2009-2012, most recently as Manager, Human Resources Consulting), and ZymoGenetics, Inc., a biotechnology/pharmaceutical company (2004-2009, most recently as Human Resources Manager). There are no arrangements or understandings between Ms. Aebersold and any other persons pursuant to which Ms. Aebersold was named as an officer. There are also no family relationships between Ms. Aebersold and any director, executive officer or person nominated to become a director or executive officer of the Company.
 
Related to Ms. Aebersold’s appointment as Vice President, Global Human Resources, the Company entered into an employment agreement with Ms. Aebersold, effective January 1, 2021 (the “Employment Agreement”). Ms. Aebersold is employed at-will, and the Employment Agreement is not for a definite time period, but rather, will continue until terminated in accordance with its terms. Pursuant to the Employment Agreement, Ms. Aebersold will earn a base salary equal to $240,000 per year plus an annual maximum bonus of 30% of Ms. Aebersold’s base salary, to be payable in cash or stock in the sole discretion of the board of the Company.
 
Ms. Aebersold will be entitled to participate in all employee benefit programs established by the Company that are applicable to management personnel. In addition, upon termination without “Cause” (other than by reason of death or disability) or resignation for “Good Reason,” Ms. Aebersold will receive the following severance payments: (i) her base salary through the date of termination, including unused vacation time and expenses, (ii) a lump sum severance payment equal to 6 months’ salary and (iii) an amount equal to the cost of 6 months' medical insurance premiums at a monthly amount equal to the amount of COBRA coverage in effect as of the termination date, plus a tax gross-up with respect to such premiums. If Ms. Aebersold’s employment is terminated within 90 days following a “Change in Control,” Ms. Aebersold is entitled to (i) her base salary through the date of termination, including unused vacation time and expenses, (ii) a lump sum severance payment equal to 6 months’ salary, (iii) 100% of any incentive cash and/or stock bonus opportunity for the current year and (iv) an amount equal to the cost of 6 months' medical insurance premiums at a monthly amount equal to the amount of COBRA coverage in effect as of the termination date, plus a tax gross-up with respect to such premiums. The Employment Agreement contains a covenant not to compete with the Company or solicit the Company's employees, customers or suppliers for a period of 1 year after the date of termination.
 
The foregoing summary of the Employment Agreement is qualified in its entirety by reference to the text of the Employment Agreement, copies of which will be attached as an exhibit to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
Biolife Solutions, Inc.
 
 
 
 
Date: January 7, 2021
By:
    /s/ Roderick de Greef
 
 
 
Name: Roderick de Greef
Title: Chief Financial Officer
 
 
 
 
 
EX-101.SCH 2 blfs-20210101.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 3 blfs-20210101_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 blfs-20210101_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Title of 12(b) Security Trading Symbol Security Exchange Name Amendment Flag Entity, Central Index Key EX-101.PRE 5 blfs-20210101_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 bioli20210107_8k_htm.xml IDEA: XBRL DOCUMENT 0000834365 2021-01-01 2021-01-01 false 0000834365 8-K 2021-01-01 BIOLIFE SOLUTIONS, INC. DE 001-36362 94-3076866 3303 Monte Villa Parkway Bothell WA 98021 425 402-1400 false false false false false BioLife Solutions, Inc. Common Stock BLFS NASDAQ XML 7 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document And Entity Information
Jan. 01, 2021
Document Information [Line Items]  
Entity, Registrant Name BIOLIFE SOLUTIONS, INC.
Document, Type 8-K
Document, Period End Date Jan. 01, 2021
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-36362
Entity, Tax Identification Number 94-3076866
Entity, Address, Address Line One 3303 Monte Villa Parkway
Entity, Address, City or Town Bothell
Entity, Address, State or Province WA
Entity, Address, Postal Zip Code 98021
City Area Code 425
Local Phone Number 402-1400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Title of 12(b) Security BioLife Solutions, Inc. Common Stock
Trading Symbol BLFS
Security Exchange Name NASDAQ
Amendment Flag false
Entity, Central Index Key 0000834365
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

" M)U(ZJJ+G0 $ #P" / " 6\/ !X;"]W;W)K8F]O:RYX M;6Q02P$"% ,4 " "7@B=2)!Z;HJT #X 0 &@ @ '< M$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " "7@B=2 M99!YDAD! #/ P $P @ '!$0 6T-O;G1E;G1?5'EP97-= :+GAM;%!+!08 "0 ) #X" +$P ! end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 96 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.blfs.com/20210101/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports bioli20210107_8k.htm blfs-20210101.xsd blfs-20210101_def.xml blfs-20210101_lab.xml blfs-20210101_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bioli20210107_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "blfs-20210101_def.xml" ] }, "inline": { "local": [ "bioli20210107_8k.htm" ] }, "labelLink": { "local": [ "blfs-20210101_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "blfs-20210101_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "blfs-20210101.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "blfs", "nsuri": "http://www.blfs.com/20210101", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "bioli20210107_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.blfs.com/20210101/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "bioli20210107_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.blfs.com/20210101/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001437749-21-000366-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-000366-xbrl.zip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